The CNS: Translating Discoveries into Therapeutics Summit 2018 covers topics such as:
- State of art CNS models and better understandable mechanism of action
- Novel and emerging CNS targets and biomarkers
- Strategic developments in neuro-pharmaceuticals, devices, and diagnostics
- Recent discoveries in neuro -imaging, -inflammation, -immunology, -degeneration, psychiatry and neurology
- Overcoming challenges to CNS drug delivery associated with blood-brain barrier (BBB)
- Advanced translational CNS strategies
- Bridging science and tech to cover translational gap and to accelerate novel CNS therapeutics Investment perspectives into neuroscience and new neurotech
The CNS: Translating Discoveries into Therapeutics Summit 2018 brings together attendees involved or interested in:
- Neurodegenerative diseases
- Central Nervous System
- Translational Neuroscience
- Computational Neuroscience
- Neuroimmunology
- Neuropharmacology
- Neuroengineering
- Neurology
- Stem Cells
- Neuropharmaceuticals
- Brain
- Neurodevices
- Blood Brain Barrier (BBB)
- Spinal Disorders
- Autism
- Arachnoid cysts
- Encephalitis
- Catalepsy
- Meningitis
- Infection
- Alzheimer’s diseases
- Multiple sclerosis
- Sleep disorders
- Parkinson`s diseases
- Neuroimaging / Brain Imaging
- Neuroscience
- Neuroinformatics
- Cognitive Neuroscience
- Neurogenetics
- Neurobiology
- Novel Neurotherapeutics
- Neurotechnology
- Cell & Gene Therapies
- Central Nervous System Regenerative Medicine
- Brain Stem
- Neurodiagnostics
- Addiction
- Biomarkers
- Bipolar disorder
- Attention deficit/hyperactivity disorder (ADHD)
- Epilepsy/Seizures
- Depression
- Migraine
- Locked-in syndrome
- Huntington`s disease
- Myelopathy
- Tourette`s diseases
